Details for New Drug Application (NDA): 083082
✉ Email this page to a colleague
NDA 083082 describes CHLOROQUINE PHOSPHATE, which is a drug marketed by Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the CHLOROQUINE PHOSPHATE profile page.
The generic ingredient in CHLOROQUINE PHOSPHATE is chloroquine phosphate. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chloroquine phosphate profile page.
The generic ingredient in CHLOROQUINE PHOSPHATE is chloroquine phosphate. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chloroquine phosphate profile page.
Summary for 083082
| Tradename: | CHLOROQUINE PHOSPHATE |
| Applicant: | Hikma Pharms |
| Ingredient: | chloroquine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 17, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
